Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
1 Assignment
0 Petitions
Accused Products
Abstract
The invention is directed to aza-bridged-bicyclic compounds having Formula (I):
and pharmaceutically acceptable salts thereof. The compounds are useful (α4 integrin receptor antagonists and, in particular, α4β1 and α4β7 integrin receptor antagonists. The invention is further directed to methods for use of the instant compounds for treating integrin mediated disorders including, but not limited to, inflammatory disorders, autoimmune disorders and cell-proliferative disorders, methods for preparing the compounds and methods for preparing the intermediates, derivatives and pharmaceutical compositions thereof.
64 Citations
57 Claims
- 1. A compound of Formula (I):
-
25. A compound having Formula (II):
-
26. A process for preparing a compound of Formula (III):
Specification